5‐Aminolevulinic Acid Fluorescence‐Guided Surgery in Head and Neck Squamous Cell Carcinoma
The Laryngoscope · 2024
DOI: 10.1002/lary.30910 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Peter Filip und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York City, New York, U.S.A. Hauptthemen laut MEDLINE: Brain Neoplasms, Head and Neck Neoplasms, Surgery, Computer-Assisted. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: NX Development Corporation.
Abstract (Originalsprache)
Objectives
To determine the utility of 5‐aminolevulinic acid (5‐ALA) fluorescence for resection of head and neck carcinoma.
Methods
In this prospective pilot trial, 5‐ALA was administered as an oral suspension 3–5 h prior to induction of anesthesia for resection of head and neck squamous cell carcinoma (HNSCC). Following resection, 405 nm blue light was applied, and fluorescence of the tumor as well as the surgical bed was recorded. Specimen fluorescence intensity was graded categorically as none (score = 0), mild (1), moderate (2), or robust (3) by the operating surgeon intraoperatively and corroborated with final pathologic diagnosis.
Results
Seven patients underwent resection with 5‐ALA. Five (83%) were male with an age range of 33–82 years (mean = 60). Sites included nasal cavity ( n = 3), oral cavity ( n = 3), and the larynx ( n = 1). All specimens demonstrated robust fluorescence when 5‐ALA was administered 3–5 h preoperatively. 5‐ALA fluorescence predicted the presence of perineural invasion, a positive margin, and metastatic lymphadenopathy. Two patients had acute photosensitivity reactions, and one patient had a temporary elevation of hepatic enzymes.
Conclusions
5‐ALA induces robust intraoperative fluorescence of HNSCC, capable of demonstrating a positive margin, perineural invasion, and metastatic nodal disease. Although no conclusions are there about the safety of this drug in the head and neck cancer population, our study parallels the extensive safety data in the neurosurgical literature. Future applications may include intraoperative assessment of margin status, diagnostic accuracy, and impacts on survival. Level of Evidence 4 Laryngoscope , 134:741–748, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York City, New York, U.S.A.
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York City, New York, U.S.A.
ORCID-Profile: Peter Filip, David K Lerner, Evan Kominsky
Förderung
- NX Development Corporation
Zitieren
APA
Filip, P., Lerner, D. K., Kominsky, E., Schupper, A., Liu, K., Khan, N. M., Roof, S., Hadjipanayis, C., Genden, E., & Iloreta, A. M. C. (2024). 5‐Aminolevulinic Acid Fluorescence‐Guided Surgery in Head and Neck Squamous Cell Carcinoma. The Laryngoscope. https://doi.org/10.1002/lary.30910
Vancouver
Filip P, Lerner DK, Kominsky E, Schupper A, Liu K, Khan NM, et al. 5‐Aminolevulinic Acid Fluorescence‐Guided Surgery in Head and Neck Squamous Cell Carcinoma. The Laryngoscope. 2024. doi:10.1002/lary.30910
BibTeX
@article{Filip2024,
author = {Filip, Peter and Lerner, David K and Kominsky, Evan and Schupper, Alexander and Liu, Katherine and Khan, Nazir Mohemmed and Roof, Scott and Hadjipanayis, Constantinos and Genden, Eric and Iloreta, Alfred M C},
title = {5‐Aminolevulinic Acid Fluorescence‐Guided Surgery in Head and Neck Squamous Cell Carcinoma},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.30910}
}
EUVIMED